Advances in Safety Pharmacology: Utilizing ipsc-derived cardiomyocytes in early stage safety pharmacology investigations. Blake Anson, PhD.
|
|
- Tyrone Cross
- 5 years ago
- Views:
Transcription
1 Advances in Safety Pharmacology: Utilizing ipsc-derived cardiomyocytes in early stage safety pharmacology investigations Blake Anson, PhD.
2 Presentation Outline I. Safety Pharmacology and in-vitro models Need for human cardiac model Potential for stem cell technology to provide a solution II. Functional characterization of stem cell derived cardiomyocytes Genomic, protein, metabolic, electrophysiological III. Methods for interrogating cardiomyocyte function Electrophysiology, Ca2+ handling, Contractility Direct and Indirect (screening) methodologies IV. Case studies Retrospective Analysis V. Summary Mechanistic and Phenotypic Approaches 2
3 Safety Pharmacology Key functional endpoints From M. Pugsley Current common in-vitro models include cell lines and non-human cellular preparations. 3
4 The Heart Beat: A Remarkable Feat! Your heart is an electrically driven pump. It usually beats times a minute, or about 100,000 times a day, or about 35 million times a year, or about 3 billion times in a normal life span. If the normal pumping rhythm is severely disrupted for more than a few minutes, irreversible multi-organ damage and death occur
5 ipsc-derived cardiomyocytes Utility Cardiotoxicity: Two basic mechanisms Drug induced Arrhythmias Torsades de Pointes (Hismanal ) Vorperian et al, JACC, 15: , Biochemical induced events o Cell Permeability o Cell energetics o Oxidative stress o Mitochondrial dysfunction o Necrosis o Apoptosis The two toxicities can be species specific and may not be causal or linked The ideal test system is species specific and biologically relevant. Human ipsc-derived cardiomyocytes 5 5 5
6 Why Human? Mammalian Heart Variability in Ventricular Action Potential Duration Larger mammals have slower rates Longer APD Greater endo to epi dispersion of repolarization 6 Guo et al, Heart Rhythm. 5: ,
7 Why Human? : Very Different Ionic Mechanisms Between Large Mammals and Rodents Human Mouse P P 7 Salama and London, J Physiol. 578:43-53,
8 8 Human Stem Cell Derived Cardiomyocytes Human cardiomyocytes ES or ipsc source material Recapitulate cardiac cellular behavior Unlimited Quantity High Purity Relevant Biology Broad End-use Platform Utility
9 Human Tissue Cells ips Cell vs. ESC Origin INDUCED PLURIPOTENT STEM CELLS NEURONAL CELLS HEMATOPOIETIC CELLS CARDIOMYOCYTES RENAL CELLS EMBRYONIC STEM CELLS HEPATOCYTES Source: CDI website;
10 Cell Purity Stem Cell-Derived Models - Requirements Quality, Quantity, Purity Key Characteristics for ipsc use in Safety Pharmacology Purity Highly pure cells yield accurate results Quantity Must be able to support large scale investigations Quality Exhibit key cellular characteristics Recapitulate normal human biology Reproducible Known and relevant genotype Target Cell (non proliferating) Non-Target Cell (proliferating) Days in Culture
11 Presentation Outline I. Safety Pharmacology and in-vitro models Need for human cardiac model Potential for stem cell technology to provide a solution II. Functional characterization of stem cell derived cardiomyocytes Genomic, protein, metabolic, electrophysiological III. Methods for interrogating cardiomyocyte function Electrophysiology, Ca2+ handling, Contractility Direct and Indirect (screening) methodologies IV. Case studies Retrospective Analysis V. Summary Mechanistic and Phenotypic Approaches
12 12 hipsc-derived Cardiomyocytes Genomic and Transcript Characterization Comparative Analyses whole genome profiling ~200 Cardiac genes were identified from the Novartis GNF expression atlas Expression levels of these genes were obtained from adult human heart mrna library (ambion) Expression levels of these genes were obtained from pure populations of ipsccardiomyocytes over a 3 month period (d028 to d120) Relative levels compared with each other Purified ipsc-cardiomyocytes (ipsc-cardiomyocytes) show a stable cardiac expression profile that matches adult human tissue Adapted from Babiarz et al., 2011
13 13 Human ipsc Cardiomyocytes Protein Expression From Kattman et al., 2011
14 14 14 Human ipsc Cardiomyocytes Metabolic Characterization ipsc-cardiomyocytes utilize non-glycolytic substrates Adapted from Rana et al., 2012 ipsc-cardiomyocyte mitochondria are functional ipsc-cardiomyocytes utilize mitochondrial oxidative phosphorylation
15 15 Human ipsc-cardiomyocytes Contractility / Ca 2+ handling Characterization Contraction Sunny Z. Sun Determined by edge detection Ca 2+ Transients
16 Human ipsc-cardiomyocytes Depolarizing Currents 16 I Na I Ca-L Ma, et al, Am. J. Physiol., 2011
17 Human ipsc-cardiomyocytes Repolarizing Currents 17 I Kr I Ks Ma, et al, Am. J. Physiol., 2011
18 ipsc-cardiomyocytes Other Currents 18 I funny I K1 I to Ma, et al, Am. J. Physiol., 2011
19 Frequency ipsc-cardiomyocytes GPCR Pathways 19 Spontaneous Action Potential Beating Rate (MEA): G as b1 Isoproterenol G aq a1 Phenylephrine G ai m2 Carbachol Concentration (mm) Control Drug ipsc Cardiomyocytes have the appropriate GPCR pathways
20 Stem Cell -Cardiomyocytes Action Potentials ipsc-cms Ma, et al, Am. J. Physiol., 2011 hes-cms Peng et al., 2010 Stem cell derived CMs exhibit cardiac like action potentials 20
21 21 21 Presentation Outline I. Safety Pharmacology and in-vitro models Need for human cardiac model Potential for stem cell technology to provide a solution II. Functional characterization of stem cell derived cardiomyocytes Genomic, protein, metabolic, electrophysiological III. Methods for interrogating cardiomyocyte function Electrophysiology, Ca 2+ handling, Contractility Direct and Indirect (screening) methodologies IV. Case studies Retrospective Analysis V. Summary Mechanistic and Phenotypic Approaches
22 The Cardiac Action Potential Schram et al. Circ Res 2002 Fares and Howlett Proc. Aus. Physi. Soc. (2009) Basic functional electrical unit Drives contraction by initiating increases in intracellular Ca 2+ levels How are these processes interrogated in-vitro?
23 23 ipsc Cardiomyocytes Safety Pharmacology - APD Assay I Na Block Decreased dv/dt I Kr Block prolonged APD EAD Generation % of control Dose Peak MDP APD10 APD50 APD90 dv/dt I Ca Block shortened APD TTX N=5 E4031 N=5 Nifedipine N=5 1μM 103.8± ± ± ± ± ±7.4 3μM 100.0± ± ± ± ± ±11.2* 10μM 99.0± ± ± ± ± ±1.8* 30μM 99.1± ± ± ± ± ±2.0* 3nM 99.0± ± ± ± ± ±4.4 10nM 100.5± ± ± ± ± ±5.9 30nM 99.3± ± ± ±3.7* 140.3±7.6* 90.1± nM 101.1± ± ± ±3.9* ±13.6* 69.4±17.1 3nM 89.5± ± ±7.1* 84.6±2.4* 89.4±1.0* 83.9± nM 82.2± ± ±12.3* 70.3±6.1* 78.4±4.4* 91.3±4.4 30nM 87.2± ± ±7.6* 65.7±3.0* 74.0±2.3* 84.8± nM 73.6± ± ±11.1* 45.4±4.5* 58.2±5.4* 87.7±8.6 ipsc-cardiomyocytes show expected pharmacology Ma, et al, Am. J. Physiol., 2011
24 hesc Cardiomyocyte AP Pharmacology Arrhythmic Triggers Response Across Ion Channel Families Quantifiable Responses hesc-cardiomyocytes show expected pharmacology Peng et al.,
25 Stem cell Cardiomyocytes recapitulate pro-arrhythmia triggers EAD amplitude varies inversely with take off potential Adult Canine Purkinje Fiber APs EAD Take off potential ipsc CM APs Bay k ±0.26 mv/mv -2.28±0.11 mv/mv January et al, Circ Res, 65:570+, 1988 Ma et al, AJP:H&C, 301:H2006+,
26 msec mv mv mv Human ipsc Cardiomyocytes Organotypic Recordings MultiElectrode Array (MEA) Technique Waveforms 1 64 wells at a time 100 uv 500 ms 100 Nifedipine E Chromanol 293B Field Potential Overlays sfapdc *** *** control 10 nm 30 nm *** 300 * * control 3 nm 10 nm 30 nm 100 nm ** 200 control 10 mm 30 mm Nifedipine (nm) E-4031 (nm) Chromanol 293B (mm) Compounds induce expected effects 26
27 Human ipsc Cardiomyocytes Multi-electrode Array Measuring Conduction Velocity ipsc Human Cardiomyocyte Field Potentials 48-well MEA plate ipsc Human Cardiomyocyte FPD Initiation depends on well position within the plate ms ipsc Conduction velocity can be measured 1 0 Drug-induced effects on conduction velocity can be measured Organotypic preparations provide additional/alternative endpoints 27
28 Beats/min Beats/min RFU ipsc Cardiomyocytes Utility Ca 2+ Measurements Calcium 5 Assay Kit (Molecular Devices) Fluorescence intensity of Ca 2+ transients from autonomously beating cells. The entire experiment was finished in 100 seconds Beat rates before and after addition of 0.3 mm epinephrine Add compound Time, sec w format Concentration, um 4-P Fit: y = (A - D)/( 1 + (x/c)^b ) + D: A B C D R^2 iso (Isoproterenol: Concentration vs MeanValue) doxa (doxazosin: Concentration vs MeanValue) vera (verapamil: Concentration vs MeanValue) epi (Epinephrine: Concentration vs MeanValue) w format Concentration, um Concentration, um Positive Chronotropes: Isoproterenol Epinephrine Dopamine 1e Negative Chronotropes: 4-P Fit: y = (A - D)/( 1 + (x/c)^b ) + D: A B C D R^2 10 Plot#1 (Astemisole: Concentration vs MeanValue) e Plot#5 (TTX: Concentration vs MeanValue) Plot#4 (Cisarpide: Concentration vs MeanValue) Plot#2 (Pimoside: Concentration vs MeanValue) e Plot#3 (Terfenadine: Concentration vs MeanValue) Weighting: Fixed 1e P Fit: y = (A - D)/( 1 + (x/c)^b ) + D: A B C D R^2 Plot#5 (Doxazosin: Concentration vs MeanValue) e e Isoproterenol (Isoproterenol: Concentration vs Me Plot#3 (Epinephrine: Concentration vs MeanValue) Plot#2 (Propanolol: Concentration vs MeanValue) verapamil (Verapamil: Concentration vs MeanVal Doxasozine Verapamil Propranolol Modified from Sirenko et al.,
29 RFU 29 ipsc Cardiomyocytes Utility Ca 2+ Imaging Calcium 5 Assay Kit (Molecular Devices) Fluorescence intensity of Ca 2+ transients from autonomously beating cells. The entire experiment was finished in 100 seconds Beat rates before and after addition of 0.3 mm epinephrine Add compound Time, sec New algorithms are being developed for analysis Calcium 5 Response on FLIPR: Epinephrine High Dose (C06) Rise Time Peak Width (FWHM) Decay Time Amplitude & Time Time (sec)
30 30 Human ipsc Cardiomyocytes Functional Utility - Contractility Contraction Determined by edge detection Sunny Z. Sun Ca 2+ Transients Puppala et al, 2012
31 Human ipsc Cardiomyocytes Relevant Mitochondrial Toxicity Screens Assess viability while inhibiting mitochondrial function (rotenone, antimycin, and oligomycin) Media matters! Context inappropriate media can mask outcomes Decreased viability is masked by glucose Adapted from Rana et al.,
32 32 32 Presentation Outline I. Safety Pharmacology and in-vitro models Need for human cardiac model Potential for stem cell technology to provide a solution II. Functional characterization of stem cell derived cardiomyocytes Genomic, protein, metabolic, electrophysiological III. Methods for interrogating cardiomyocyte function Electrophysiology, Ca 2+ handling, Contractility Direct and Indirect (screening) methodologies IV. Case studies Retrospective Analysis V. Summary Mechanistic and Phenotypic Approaches
33 RFU 33 ipsc Cardiomyocytes Screening Ca 2+ Imaging reflects electrical activity Calcium 5 Assay Kit (Molecular Devices) Fluorescence intensity of Ca 2+ transients from autonomously beating cells. The entire experiment was finished in 100 seconds Beat rates before and after addition of 0.3 mm epinephrine Add compound Time, sec Electrical activity at the membrane is reflected in the Ca 2+ transient Calcium 5 Response on FLIPR: Epinephrine High Dose (C06) Calcium 5 Dye Response on FLIPR - Cisapride High Does (I12) Width ~ 1 sec Width ~ 8 sec Time (sec) Time (ms)
34 Relative Light Units Peak Count (120 sec) Relative Light Units Peak Count (120 sec) 34 ipsc-cardiomyocytes Screening FLIPR Tetra System - Quantitation No Treatment K7 - Group:Cisapride_9 - Concentration: mm Cisapride I7 - Group:Cisapride_7 - Concentration: pride ntration: Time (Seconds) Cisapride 15 min post addition EC/IC50 = Time (Seconds) Intracellular Ca 2+ oscillations can be used to measure membrane ion channel activity In well plates [Cisapride] (um)
35 Human ipsc Cardiomyocytes Label-Free Monitoring xcelligence RTCA Cardio Cell Index (log) Gold electrode Increasing Impedance 10 1 Seconds Slide modified from K. Kolaja 96-well E-eplate Time (hour) A surrogate measurement platform for electrical activity, Ca 2+ handling, contractility
36 ipsc-cardiomyocytes - Utility Label-Free Measurements Arrhythmogenesis Arrhythmia Screening in 96-wells More predictive than current models Identifies False Negatives identifies False Positives Guo et al., PPS - Predicted ProArhythmia Score 36
37 Presentation Outline I. Safety Pharmacology and in-vitro models Need for human cardiac model Potential for stem cell technology to provide a solution II. Functional characterization of stem cell derived cardiomyocytes Genomic, protein, metabolic, electrophysiological III. Methods for interrogating cardiomyocyte function Electrophysiology, Ca 2+ handling, Contractility Direct and Indirect (screening) methodologies IV. Case studies Retrospective Analysis V. Summary Mechanistic and Phenotypic Approaches
38 Example 1 38
39 Example 1 39
40 Example 2 40
41 Example 2 41
42 42 42 Presentation Outline I. Safety Pharmacology and in-vitro models Need for human cardiac model Potential for stem cell technology to provide a solution II. Functional characterization of stem cell derived cardiomyocytes Genomic, protein, metabolic, electrophysiological III. Methods for interrogating cardiomyocyte function Electrophysiology, Ca2+ handling, Contractility Direct and Indirect (screening) methodologies IV. Case studies Retrospective Analysis V. Summary Mechanistic and Phenotypic Approaches
43 Mechanistic Approach Functional Endpoints Example subset Process Cell Biology Wetware Endpoint Platform Electrical activity Ion channels GPCRs AP perturbation Chronotropic changes Patch Clamp, MEA, FliPR, HCI, Label-free Ca 2+ handling RYR2 SERCA Release and uptake FliPR, HCI, labelfree Contractility Contractile filaments Inotropic changes HCI, Ionoptix, label-free Bioenergetics Fatty Acid Oxidation Lipid Metabolism Mitochondrial function ATP production Oxygen consumption, mitochondrial dyes
44 Mechanistic Approach Functional Endpoints Example subset Process Cell Biology Wetware Endpoint Platform Electrical activity Ion channels GPCRs AP perturbation Chronotropic changes Patch Clamp, MEA, FliPR, HCI, Label-free Ca 2+ handling RYR2 SERCA Release and uptake FliPR, HCI, labelfree Contractility Contractile filaments Inotropic changes HCI, Ionoptix, label-free Bioenergetics Fatty Acid Oxidation Lipid Metabolism Mitochondrial function ATP production Oxygen consumption, mitochondrial dyes adverse signal Phenotypic Approach Consistent output Surrogate measurements
45 45 Summary Human Stem Cell Derived Cardiomyocytes Human cardiomyocytes Provide an in-vitro recapitulation of native cellular biology and physiology Can be used across a variety of interrogation platforms Have, in some cases, shown greater utility than current models Can be used for phenotypic and mechanistic screening investigations
46 Thank-you
Human induced pluripotent stem cell derived cardiomyocytes are a more relevant model for assessing drug-induced effects on mitochondrial function
Human induced pluripotent stem cell derived cardiomyocytes are a more relevant model for assessing drug-induced effects on mitochondrial function than H9C2 cells 16 January 2013 SLAS2013 Presentation Outline
More informationAssessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes. on the ACEA xcelligence RTCA CardioECR
Assessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes on the ACEA xcelligence RTCA CardioECR Application Note Version 2.1 / March 2018 Contents 1. Introduction 1 2. Assessment of pro-arrhythmic
More informationMeasuring Cardiac Activity:
icell Cardiomyocytes Application Protocol Measuring Cardiac Activity: Intracellular Calcium Flux Detection on the FLIPR Tetra System Introduction icell Cardiomyocytes are human cardiomyocytes that recapitulate
More informationNcardia. Assessment of pro-arrhythmic effects in Pluricyte Cardiomyocytes. using the Axion BioSystems Maestro TM MEA system
Ncardia Stem cell experts Assessment of pro-arrhythmic effects in Pluricyte Cardiomyocytes using the Axion BioSystems Maestro TM MEA system Application note Version 2.0 Contents 1. Introduction 1 2. Assessment
More informationTdP Mechanisms and CiPA
TdP Mechanisms and CiPA Craig T. January, MD, PhD Division of Cardiovascular Medicine University of Wisconsin-Madison Cardiac Safety Research Consortium Hilton Washington DC December 6, 2016 Disclosures
More informationMetrion Biosciences: the ion channel specialists
Metrion Biosciences: the ion channel specialists In depth profiling of human ipsc cardiomyocytes: From electrophysiology to phenotypic assays Saïd El-Haou, PhD 30 November 2017 www.metrionbiosciences.com
More informationWelcome to the Exhibitor Tutorial presented by
Welcome to the Exhibitor Tutorial presented by February 1, 217 1 Calcium Handling Assays with Human ipsc-derived Cell Types Coby Carlson, Ph.D. 7 February 217 Transformative Potential of ipsc Technology
More informationMechanisms of Arrhythmogenesis: Focus on Long QT Syndrome (LQTS)
Mechanisms of Arrhythmogenesis: Focus on Long QT Syndrome (LQTS) Craig T. January, MD, PhD Division of Cardiovascular Medicine University of Wisconsin-Madison CSRC-HESI-FDA Rechanneling the Current Cardiac
More informationEffects of reference compounds on impedance signals from stem cellderived human cardiomyocytes
Effects of reference compounds on impedance signals from stem cellderived human cardiomyocytes Herbert M. Himmel, Safety Pharmacology, Bayer Pharma AG, Wuppertal, Germany SPS Webinar Cardiac Safety Testing
More informationxcelligence System RTCA Cardio Instrument
xcelligence System Application Note No. 15 January 2013 xcelligence System RTCA Cardio Instrument Preclinical Cardiac Safety Assessment using Human ipsc Derived icell TM Cardiomyocytes Introduction Over
More informationCardiomyocyte? March 14 th 2013
What Makes a Cardiomyocyte a Cardiomyocyte? Kyle Kolaja March 14 th 2013 What Makes a Cardiomyocyte a Cardiomyocyte? Shouldn t proliferate Should beat Should be fairly pure Should look like and express
More informationMeasuring Cardiac Activity:
icell Cardiomyocytes 2 Application Protocol Measuring Cardiac Activity: Impedance Detection with xcelligence RTCA Cardio System Introduction icell Cardiomyocytes 2, human cardiomyocytes derived from induced
More informationmesc Derived Cardiomyocytes and the RTCA Cardio Instrument - The Perfect Match for Screening Cardiac Effects
mesc Derived Cardiomyocytes and the RTCA Cardio Instrument - The Perfect Match for Screening Cardiac Effects Dr. Kristina Tressat, Axiogenesis AG ELRIG Drug Discovery II 7-8 Sep 2011, Manchester Challange
More informationMultiparametric assessment of the effects of chemotherapeutic drugs on the (electro)physiology of Pluricyte Cardiomyocytes
Multiparametric assessment of the effects of chemotherapeutic drugs on the (electro)physiology of Pluricyte Cardiomyocytes Event Presenter Date Ncardia Workshop Tessa de Korte, MSc December 1, 2017 Page
More informationInPulse: Development of an ipsc cardiomyocyte (ipsc-cm) platform to assess drug-induced contractility liabilities.
InPulse: Development of an ipsc cardiomyocyte (ipsc-cm) platform to assess drug-induced contractility liabilities. Sponsors: Arun Sridhar, Peter J. Clements, Brian Berridge, Drug induced contractility
More informationAssessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes on the ACEA xcelligence RTCA CardioECR
Assessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes on the ACEA xcelligence RTCA CardioECR Version 1.2 CONTENTS Getting started... 3 Technical support and training... 3 1. Introduction...
More informationmicroheart: A screening-ready, physiologically relevant human ipsc-derived cardiomyocyte platform.
: A screening-ready, physiologically relevant human ipsc-derived cardiomyocyte platform. Human induced Pluripotent Stem Cells (hipscs) enable assays with human, patient and organ/system-specific cells
More informationMultiparameter In Vitro Assessment of Compound Effects on Cardiomyocyte Physiology Using ipsc Cells
457590JBXXXX10.1177/1087057112457590Jo urnal of Biomolecular ScreeningSirenko et al. 2012 Multiparameter In Vitro Assessment of Compound Effects on Cardiomyocyte Physiology Using ipsc Cells Journal of
More informationAssessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes. on the ACEA xcelligence RTCA CardioECR
Assessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes on the ACEA xcelligence RTCA CardioECR User Guide Version 3.0 / March 2018 Contents 1. Introduction 2 2. Workflow 3 3. Important recommendations
More informationxcelligence RTCA Cardio Instrument Monitor Cardiomyocyte Beating in Real Time for Drug Discovery Research
xcelligence RTCA Cardio Instrument Monitor Cardiomyocyte Beating in Real Time for Drug Discovery Research xcelligence RTCA Cardio Instrument A new way to test for compound cardiotoxicity Cardiac liability
More informationMEA assays using human ipsc-derived cardiomyocytes; challenges and opportunities
MEA assays using human ipsc-derived cardiomyocytes; challenges and opportunities Event Presenter Date EMA Workshop 2017 Tessa de Korte, MSc 2017, October 5 Page 1 Ncardia at a glance Foundation Ncardia
More informationAssessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes on the Axion Maestro system
Assessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes on the Axion Maestro system Version 1.0 CONTENTS Getting started... 3 Technical support and training... 3 1. Introduction... 4 2. Workflow...
More informationPerforming Bioenergetic Analysis: Seahorse XFe96 Analyzer
icell Cardiomyocytes 2 Application Protocol Performing Bioenergetic Analysis: Seahorse XFe96 Analyzer Introduction The myocardium is the most metabolically active tissue in the body and is highly sensitive
More informationWe ve crossed the Chasm and climbed out of the Trough. Advances and advantages with ipsc-derived cell types in drug discovery.
We ve crossed the Chasm and climbed out of the Trough. Advances and advantages with ipsc-derived cell types in drug discovery. Blake Anson Ph.D. Oct 31, 2014 Technology Hype Cycle The Chasm The Trough
More informationMeasuring Cardiac Activity:
icell Cardiomyocytes 2 Application Protocol Measuring Cardiac Activity: Impedance and Extracellular Field Potential Detection with CardioExcyte 96 System Introduction icell Cardiomyocytes 2, human cardiomyocytes
More informationChapter 12: Cardiovascular Physiology System Overview
Chapter 12: Cardiovascular Physiology System Overview Components of the cardiovascular system: Heart Vascular system Blood Figure 12-1 Plasma includes water, ions, proteins, nutrients, hormones, wastes,
More informationSuccesses and Evolving Challenges Posed by the Comprehensive In Vitro Proarrhythmia (CiPA) Initiative
Successes and Evolving Challenges Posed by the Comprehensive In Vitro Proarrhythmia (CiPA) Initiative Gary Gintant Dept. Integrative Pharmacology Integrated Sciences and Technology AbbVie For the CiPA
More informationAssessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes on the Axion BioSystems Maestro TM MEA system
Assessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes on the Axion BioSystems Maestro TM MEA system Version 1.2 CONTENTS Getting started... 3 1. Introduction... 4 2. Workflow... 5 Important
More informationFrom Bench to Practice: Cardiac Resynchronisation Therapy
From Bench to Practice: Cardiac Resynchronisation Therapy Molecular Changes in the Dyssynchronous Heart and Cardiac Resynchronisation Therapy Gordon F. Tomaselli, M.D. Professor of Medicine and Molecular
More informationPluricyte Cardiomyocytes. using the Multiwell MEA System from Multi Channel Systems
Pluricyte Cardiomyocytes using the Multiwell MEA System from Multi Channel Systems User Guide Version 3.1 / March 2018 Contents 1. Introduction 2 2. Workflow 3 3. Important Recommendations 4 4. Equipment,
More informationDepartment of medical physiology 7 th week and 8 th week
Department of medical physiology 7 th week and 8 th week Semester: winter Study program: Dental medicine Lecture: RNDr. Soňa Grešová, PhD. Department of medical physiology Faculty of Medicine PJŠU Cardiovascular
More informationBenchmarking In Silico Models and Candidate Metrics for Assessing the Risk of Torsade de Pointes
Benchmarking In Silico Models and Candidate Metrics for Assessing the Risk of Torsade de Pointes Sara Dutta Division of Applied Regulatory Science/OCP/CDER CRSC/HESI/SPS/FDA Meeting December 11, 2014 Silver
More informationPluricyte Cardiomyocytes
Pluricyte Cardiomyocytes Manual Version 2.1 / March 2018 Contents 1. Introduction 2 2. Equipment, Materials and Reagents 3 3. Methods 4 3.1 Coating of tissue culture plates 4 3.2 Thawing Pluricyte Cardiomyocytes
More informationIn Vitro Assessment to Replace the Clinical TQT Study: The Comprehensive In Vitro ProArrhythmia Assay (CiPA) Initiative
In Vitro Assessment to Replace the Clinical TQT Study: The Comprehensive In Vitro ProArrhythmia Assay (CiPA) Initiative Gary Gintant, AbbVie for the Comprehensive in Vitro ProArrhythmia Assay Group Hot
More informationPluricyte Cardiomyocytes. Axion BioSystems Maestro TM MEA system
Pluricyte Cardiomyocytes Axion BioSystems Maestro TM MEA system User Guide Version 3.0 / March 2018 Contents 1. Introduction 2 2. Workflow 3 3. Important recommendations 4 4. Equipment, Materials and
More informationComparison of Electrophysiological Data From Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes to Functional Preclinical Safety Assays
toxicological sciences 134(2), 412 426 2013 doi:10.1093/toxsci/kft113 Advance Access publication May 20, 2013 Comparison of Electrophysiological Data From Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes
More informationHHS Public Access Author manuscript Circ Res. Author manuscript; available in PMC 2016 June 05.
Tissue and Animal Models of Sudden Cardiac Death Karim Sallam, MD *,1,2,3, Yingxin Li, PhD *,1,2,3, Philip T. Sager, MD 1,2, Steven R. Houser, PhD 4, and Joseph C. Wu, MD, PhD 1,2,3 1 Stanford Cardiovascular
More informationxcelligence Cardio Symposium 2014 Cardiotoxicity, QT Prolongation, and Arrhythmia Prediction Using icell Cardiomyocytes: Past, Present, and Future
xcelligence Cardio Symposium 2014 Cardiotoxicity, QT Prolongation, and Arrhythmia Prediction Using icell Cardiomyocytes: Past, Present, and Future Blake Anson Ph.D. Oct 18, 2014 Outline Proarrhythmia Testing
More informationInternational Graduate Research Programme in Cardiovascular Science
1 International Graduate Research Programme in Cardiovascular Science This work has been supported by the European Community s Sixth Framework Programme under grant agreement n LSHM-CT-2005-01883 EUGeneHeart.
More informationChapter 10! Chapter 10, Part 2 Muscle. Muscle Tissue - Part 2! Pages !
! Chapter 10, Part 2 Muscle Chapter 10! Muscle Tissue - Part 2! Pages 308-324! SECTION 10-5! Sarcomere shortening and muscle fiber stimulation produce tension! 2! Tension Production - Muscle FIBER! All-or-none
More informationMuscle and Muscle Tissue
Muscle and Muscle Tissue Make up about half of total body mass Exerts force by converting chemical energy, ATP, to mechanical energy Muscle tissue is classified based on Shape Number and position of nuclei
More informationPerspectives on Evaluating and Managing Cardiovascular Safety Risk for Anticancer Drugs
Perspectives on Evaluating and Managing Cardiovascular Safety Risk for Anticancer Drugs DCTD/DTP/TPB Myrtle Davis, DVM, Ph.D. Chief, Toxicology and Pharmacology Branch Division of Cancer Treatment and
More informationJournal of Molecular and Cellular Cardiology
Journal of Molecular and Cellular Cardiology 77 (214) 178 191 Contents lists available at ScienceDirect Journal of Molecular and Cellular Cardiology journal homepage: www.elsevier.com/locate/yjmcc Original
More informationProgress in Biophysics and Molecular Biology
Progress in Biophysics and Molecular Biology 110 (2012) 166e177 Contents lists available at SciVerse ScienceDirect Progress in Biophysics and Molecular Biology journal homepage: www.elsevier.com/locate/pbiomolbio
More informationWhat Can We Learn From Integrative Modeling of the Heart?
What Can We Learn From Integrative Modeling of the Heart? Raimond L. Winslow The Institute for Computational Medicine & Department of Biomedical Engineering The Johns Hopkins University 1 The Human Heart
More informationSkeletal Muscle. Connective tissue: Binding, support and insulation. Blood vessels
Chapter 12 Muscle Physiology Outline o Skeletal Muscle Structure o The mechanism of Force Generation in Muscle o The mechanics of Skeletal Muscle Contraction o Skeletal Muscle Metabolism o Control of Skeletal
More informationIntroduction. Circulation
Introduction Circulation 1- Systemic (general) circulation 2- Pulmonary circulation carries oxygenated blood to all parts of the body carries deoxygenated blood to the lungs From Lt. ventricle aorta From
More informationRyan McGarrigle, Ph.D.
Cardiomyocyte function characterised through combined analysis of metabolic flux, beat rate and cellular oxygenation and its application in in vitro ischemia reperfusion modelling Ryan McGarrigle, Ph.D.
More informationChapter 10! Muscle Tissue - Part 2! Pages ! SECTION 10-5! Sarcomere shortening and muscle fiber stimulation produce tension!
! Chapter 10, Part 2 Muscle Chapter 10! Muscle Tissue - Part 2! Pages 308-324! SECTION 10-5! Sarcomere shortening and muscle fiber stimulation produce tension! 2! 1 Tension Production - MUSCLE FIBER! All-or-none
More informationCollin County Community College
Collin County Community College BIOL. 2402 Anatomy & Physiology WEEK 5 The Heart 1 The Heart Beat and the EKG 2 1 The Heart Beat and the EKG P-wave = Atrial depolarization QRS-wave = Ventricular depolarization
More informationCardiac Properties MCQ
Cardiac Properties MCQ Abdel Moniem Ibrahim Ahmed, MD Professor of Cardiovascular Physiology Cairo University 2007 1- Cardiac Valves: a- Prevent backflow of blood from the ventricles to the atria during
More informationConduction System of the Heart
Conduction System of the Heart -Conduction system is very important; without it we will not have impulses or action potentials and there will be NO contraction of the heart muscle. -It consists of modified
More informationSystems Biology Across Scales: A Personal View XXVII. Waves in Biology: Cardiac Arrhythmia. Sitabhra Sinha IMSc Chennai
Systems Biology Across Scales: A Personal View XXVII. Waves in Biology: Cardiac Arrhythmia Sitabhra Sinha IMSc Chennai The functional importance of biological waves Spiral Waves Cardiac Arrhythmias Arrhythmias:
More informationCh 12: Muscles sarcolemma, t-tubules, sarcoplasmic reticulum, myofibrils, myofilaments, sarcomere...
Ch 12: Muscles Review micro-anatomy of muscle tissue Terminology examples: sarcolemma, t-tubules, sarcoplasmic reticulum, myofibrils, myofilaments, sarcomere... SLOs Differentiate levels of muscle structure:
More informationCell Injury MECHANISMS OF CELL INJURY
Cell Injury MECHANISMS OF CELL INJURY The cellular response to injurious stimuli depends on the following factors: Type of injury, Its duration, and Its severity. Thus, low doses of toxins or a brief duration
More informationValidation and Utility of Human ips-vascular Smooth Muscle Cells as an in vitro Vascular Model
Validation and Utility of Human ips-vascular Smooth Muscle Cells as an in vitro Vascular Model Caroline Archer, Senior Scientist (Drug Safety and Metabolism) 30 th November 2017 Background Drug-induced
More informationConduction System of the Heart. Faisal I. Mohammed, MD, PhD
Conduction System of the Heart Faisal I. Mohammed, MD, PhD 1 Objectives l List the parts that comprise the conduction system l Explain the mechanism of slow response action potential (pacemaker potential)
More information*Generating blood pressure *Routing blood: separates. *Ensuring one-way blood. *Regulating blood supply *Changes in contraction
*Generating blood pressure *Routing blood: separates pulmonary and systemic circulations *Ensuring one-way blood flow: valves *Regulating blood supply *Changes in contraction rate and force match blood
More informationDiffering responses of human stem cell-derived cardiomyocytes to arrhythmogenic drugs, determined using impedance measurements
Fundamental Toxicological Sciences (Fundam. Toxicol. Sci.) Vol.3, No.2, 47-53, 2016 47 Letter Differing responses of human stem cell-derived cardiomyocytes to arrhythmogenic drugs, determined using impedance
More informationBIPN 100 F15 (Kristan) Human Physiology Lecture 10. Smooth muscle p. 1
BIPN 100 F15 (Kristan) Human Physiology Lecture 10. Smooth muscle p. 1 Terms you should understand: smooth muscle, L-type Ca ++ channels, actin, myosin, sarcoplasmic reticulum (SR), myosine phosphatase,
More informationDifferences in cardiac atrial and ventricular ion channels
Differences in cardiac atrial and ventricular ion channels Norbert Jost, PhD Department of Pharmacology & Pharmacotherapy, University of Szeged Division for Cardiovascular Pharmacology, Hungarian Academy
More informationDrug-induced arrhythmogenesis. Prediction and Mechanisms. Blanca Rodriguez and Computational Biology Group University of Oxford
Drug-induced arrhythmogenesis. Prediction and Mechanisms Blanca Rodriguez and Computational Biology Group University of Oxford Feb 3 rd, 29 Work done by Esther Pueyo, Lucia Romero, Alberto Corrias, Martin
More informationCardiac toxicity is a leading cause for drug attrition during. Molecular Cardiology
Molecular Cardiology Drug Screening Using a Library of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity Ping Liang, MD, PhD*; Feng Lan, PhD*;
More informationChapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy
Chapter 9 Cardiac Arrhythmias Learning Objectives Define electrical therapy Explain why electrical therapy is preferred initial therapy over drug administration for cardiac arrest and some arrhythmias
More informationhipsc Cardiomyocytes: Validation Study Results
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH OFFICE OF SCIENCE AND ENGINEERING LABORATORIES hipsc Cardiomyocytes: Validation Study Results Ksenia Blinova, PhD US Food and Drug Administration HESI-CSRC CiPA
More informationThe mechanism of the cardiac arrhythmias Norbert Jost, PhD
The mechanism of the cardiac arrhythmias Norbert Jost, PhD Department of Pharmacology & Pharmacotherapy, University of Szeged Division for Cardiovascular Pharmacology, Hungarian Academy of Sciences Szeged,
More informationIon channel dysfunction and diseases of the heart
Basisvorlesung (BVO) Zelluläre Signaltransduktion- Krankheitsbilder Sommersemester 2015 902.384 PhD- Programm Molecular Signal Transduction Ion channel dysfunction and diseases of the heart H. Todt Dpt.
More informationDrug-induced effects on the heart: insights from HPC simulations
Drug-induced effects on the heart: insights from HPC simulations Blanca Rodriguez Computational Biology Group University of Oxford July 1 st, 2009 Acknowledgements Esther Pueyo, Lucia Romero, Alberto Corrias,
More informationWhere are the normal pacemaker and the backup pacemakers of the heart located?
CASE 9 A 68-year-old woman presents to the emergency center with shortness of breath, light-headedness, and chest pain described as being like an elephant sitting on her chest. She is diagnosed with a
More informationBasics of skeletal muscle electrophysiology. Tóth András, PhD
Basics of skeletal muscle electrophysiology Tóth András, PhD Topics Structure Contraction and relaxation Activation Excitation-contraction coupling Action potential Ion channels* Calcium homeostasis Structure
More informationCardiac physiology. b. myocardium -- cardiac muscle and fibrous skeleton of heart
I. Heart anatomy -- general gross. A. Size/orientation - base/apex B. Coverings D. Chambers 1. parietal pericardium 2. visceral pericardium 3. Layers of heart wall a. epicardium Cardiac physiology b. myocardium
More informationHuman TRPC6 Ion Channel Cell Line
TECHNICAL DATA SHEET ValiScreen Ion Channel Cell Line Caution: For Laboratory Use. A research product for research purposes only Human TRPC6 Ion Channel Cell Line Product No.: AX-012-C Lot No.: 512-548-A
More informationProblem sets will NOT be accepted late. Solutions will be posted on the web.
MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel NAME TA SEC 7.012 Problem Set 6 FRIDAY November 19,
More informationA New Comprehensive Translational Paradigm Using Human ipsc-derived Cardiomyocytes for Safety Assessment of Drug-Induced Arrhythmias
A New Comprehensive Translational Paradigm Using Human ipsc-derived Cardiomyocytes for Safety Assessment of Drug-Induced Arrhythmias Armando Lagrutta Safety & Exploratory Pharmacology (SEP) Department
More informationaxion Protocol Cell Culture on Microelectrode Arrays Cell Type: Cryopreserved Human ipsc-derived Neurons BioSystems v. 1.1
axion BioSystems Cell Culture on Microelectrode Arrays Cell Type: Cryopreserved Human ipsc-derived Neurons Protocol v. 1.1 Trademarks Axion BioSystems, Inc. and the logo are trademarks of Axion BioSystems,
More informationThe Application of Cell-Based Impedance Technology in Drug Discovery
The Application of Cell-Based Impedance Technology in Drug Discovery Yama A. Abassi, PhD Sr. Director Cell Biology and Assay Development ACEA Biosciences ACEA Biosciences Founded in early Located in San
More informationSkeletal Muscle and the Molecular Basis of Contraction. Lanny Shulman, O.D., Ph.D. University of Houston College of Optometry
Skeletal Muscle and the Molecular Basis of Contraction Lanny Shulman, O.D., Ph.D. University of Houston College of Optometry Like neurons, all muscle cells can be excited chemically, electrically, and
More informationPhase 2 Early Afterdepolarization as a Trigger of Polymorphic Ventricular Tachycardia in Acquired Long-QT Syndrome
Phase 2 Early Afterdepolarization as a Trigger of Polymorphic Ventricular Tachycardia in Acquired Long-QT Syndrome Direct Evidence From Intracellular Recordings in the Intact Left Ventricular Wall Gan-Xin
More informationFrom Patients to Therapies. How could the BADIPS challenge progress towards improved in vitro models and novel patient therapies?
From Patients to Therapies How could the BADIPS challenge progress towards improved in vitro models and novel patient therapies? 1 Aim of the BADIPS project 2 Overall objective BADIPS project The development
More informationElectrocardiographic Markers Associated with Sotalol-induced Torsades de Pointes
Electrocardiographic Markers Associated with Sotalol-induced Torsades de Pointes Based on Data from the Telemetric and Holter ECG Warehouse (THEW) Initiative Jean-PhiIippe Couderc, PhD Center for Quantitative
More informationThe action potential and the underlying ionic currents. Norbert Jost, PhD
The action potential and the underlying ionic currents Norbert Jost, PhD The propagation of the stimulation in the heart Sinus node Left atria His Bundle Conduction velocity in m/s Time to arrive from
More informationCardiac Safety Assessment. In-Vitro/In-Vivo Extrapolation
Cardiac Safety Assessment In-Vitro/In-Vivo Extrapolation Drugs removed from the market for arrhythmia risk Courtesy of Dr. Norman Stockbridge Copyright 2014 Certara, L.P. All rights reserved. 2 Let s have
More informationQUIZ/TEST REVIEW NOTES SECTION 1 CARDIAC MYOCYTE PHYSIOLOGY [CARDIOLOGY]
QUIZ/TEST REVIEW NOTES SECTION 1 CARDIAC MYOCYTE PHYSIOLOGY [CARDIOLOGY] Learning Objectives: Describe the ionic basis of action potentials in cardiac contractile and autorhythmic cells Explain the relationship
More informationStructure of the striated muscle general properties
Structure of the striated muscle general properties Structure of the striated muscle membrane systems 1. Myofibrillum (contractile proteins) 2. Sarcoplasmic reticulum (SR) longitudinal tubule 3. SR terminal
More informationRegulation of intracellular Na 1 in health and disease: pathophysiological mechanisms and implications for treatment
OPEN ACCESS Review article Regulation of intracellular 1 in health and disease: pathophysiological mechanisms and implications for treatment Raffaele Coppini 1, *, Cecilia Ferrantini 2, Luca Mazzoni 1,
More informationDevelopment and Use of Quantitative Adverse Outcome Pathways: Lessons Learned from Application to Cardiotoxicity
Development and Use of Quantitative Adverse Outcome Pathways: Lessons Learned from Application to Cardiotoxicity Chemicals Concentration 0.1 µm 1 µm 10 µm 100 µm Weihsueh A. Chiu, PhD Department of Veterinary
More informationThe Effects of Extracellular Calcium Removal on Sino-atrial Node Cells Treated with Potassium-depleted Solutions
Short Communication Japanese Journal of Physiology, 36, 403-409, 1986 The Effects of Extracellular Calcium Removal on Sino-atrial Node Cells Treated with Potassium-depleted Solutions Shun-ichi MIYAMAE
More informationMedical Cyber-Physical Systems
Medical Cyber-Physical Systems Electrophysiology basics Lecture 10 Principles of Modeling for Cyber-Physical Systems Instructor: Madhur Behl Many thanks to: Zhihao Jiang, Houssam Abbas, and Rahul Mangharam,
More informationHuman Pluripotent Stem Cell Cardiomyocyte Differentiation Kit (PSCCDK) Introduction Kit Components Cat. # # of vials Reagent Quantity Storage
Human Pluripotent Stem Cell Cardiomyocyte Differentiation Kit (PSCCDK) Catalog #5901 Introduction Human pluripotent stem cells (hpsc), including embryonic stem cells (ESC) and induced pluripotent stem
More informationInduced Pluripotent Stem Cells: an Introduction Oren Caspi MD, PhD
Induced Pluripotent : an Introduction Oren Caspi MD, PhD The Sohnis laboratory for cardiac electrophysiology and regenerative medicine The Bruce Rappaport Faculty of Medicine, Technion - Israel Institute
More informationThe Cardiovascular System
Chapter 18 Part A The Cardiovascular System 1/19/16 1 Annie Leibovitz/Contact Press Images Similarities of Cardiac and Skeletal Muscle RMP Ion concentration Deploarization Action Potential Repolarization
More informationEvolution of strategies to improve preclinical cardiac safety testing
OPINION Evolution of strategies to improve preclinical cardiac safety testing Gary Gintant, Philip T. Sager and Norman Stockbridge Abstract The early and efficient assessment of cardiac safety liabilities
More informationAbout This Chapter. Skeletal muscle Mechanics of body movement Smooth muscle Cardiac muscle Pearson Education, Inc.
About This Chapter Skeletal muscle Mechanics of body movement Smooth muscle Cardiac muscle Skeletal Muscle Usually attached to bones by tendons Origin: closest to the trunk or to more stationary bone Insertion:
More informationCardiovascular System: The Heart
Cardiovascular System: The Heart I. Anatomy of the Heart (See lab handout for terms list) A. Describe the size, shape and location of the heart B. Describe the structure and function of the pericardium
More informationChapter 14. Agents used in Cardiac Arrhythmias
Chapter 14 Agents used in Cardiac Arrhythmias Cardiac arrhythmia Approximately 50% of post-myocardial infarction fatalities result from ventricular tachycarida (VT) or ventricular fibrillation (VF). These
More informationCardiac Arrhythmias. For Pharmacists
Cardiac Arrhythmias For Pharmacists Agenda Overview of the normal Classification Management Therapy Conclusion Cardiac arrhythmias Overview of the normal Arrhythmia: definition From the Greek a-, loss
More informationInterpreting Electrocardiograms (ECG) Physiology Name: Per:
Interpreting Electrocardiograms (ECG) Physiology Name: Per: Introduction The heart has its own system in place to create nerve impulses and does not actually require the brain to make it beat. This electrical
More informationFocus Application. Compound-Induced Cytotoxicity
xcelligence System Real-Time Cell Analyzer Focus Application Compound-Induced Cytotoxicity For life science research only. Not for use in diagnostic procedures. Featured Study: Using the Time Resolving
More informationFocus Application. Compound-Induced Cytotoxicity
xcelligence System Real-Time Cell Analyzer Focus Application Compound-Induced Cytotoxicity Featured Study: Using the Time Resolving Function of the xcelligence System to Optimize Endpoint Viability and
More informationPhysiology sheet #2. The heart composed of 3 layers that line its lumen and cover it from out side, these layers are :
Physiology sheet #2 * We will talk in this lecture about cardiac muscle physiology, the mechanism and the energy sources of their contraction and intracellular calcium homeostasis. # Slide 4 : The heart
More information